BRUCE MANN: Open Payments
NPI 1285607911 · TAMARAC, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,731 in 61 payments from 14 companies in 2025. Trend: 2023 $1,231 · 2024 $1,061 · 2025 $1,731
Food & beverage: $1,731
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 20 | $436 |
| Globus Medical, Inc. | 3 | $244 |
| Abbott Laboratories | 7 | $231 |
| Valinor Pharma, LLC | 10 | $182 |
| BIOTRONIK NRO, Inc. | 1 | $143 |
| Medtronic, Inc. | 1 | $125 |
| PROTEGA PHARMACEUTIALS INC | 5 | $114 |
| Forte Bio-Pharma LLC | 3 | $70 |
| ABBVIE INC. | 2 | $50 |
| Collegium Pharmaceutical, Inc. | 2 | $33 |
Products named: RELISTOR, PROCLAIM, MOVANTIK, Vyrsa V1, KYPHON EXPRESS II KYPHOPAK TRAY, ROXYBOND, Senza, BOTOX.
Industry payments across FL — which companies pay providers there.
